At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PRME Prime Medicine, Inc.
Closed Mourning Day 01-08 16:00:00 EST
3.15
-0.13
-3.96%
盘后3.11
-0.04-1.27%
19:48 EST
High3.28
Low3.09
Vol503.93K
Open3.26
D1 Closing3.28
Amplitude5.64%
Mkt Cap401.93M
Tradable Cap166.97M
Total Shares127.60M
T/O1.59M
T/O Rate0.95%
Tradable Shares53.01M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Is Prime Medicine (PRME) Among the Top CRISPR Stocks to Invest In?
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. The company offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. It has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is based in Cambridge, Massachusetts.